Perioperative management of the bariatric surgery patient: focus on cardiac and anesthesia considerations.

Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Cleveland Clinic Journal of Medicine (Impact Factor: 3.37). 04/2006; 73 Suppl 1(Suppl_1):S51-6. DOI: 10.3949/ccjm.73.Suppl_1.S51
Source: PubMed

ABSTRACT Obesity is a major public health problem in developed nations worldwide. Currently, the only treatment for severe obesity (BMI > or = 35 kg/m2 with comorbidity) that provides long-term weight loss is bariatric surgery. Restrictive, malabsorptive, and combination procedures have been developed. Each type of procedure has its merits and unique set of risks and complications. Weight loss after bariatric surgery is accompanied by predictable improvement or resolution of obesity-related comorbidities and improved quality of life and life expectancy. Candidates for bariatric surgery are often at high risk for complications because of obesity-related comorbidities. Therefore, careful patient selection for bariatric surgery, together with well-designed strategies for preventing and managing complications, are keys to success. Close monitoring for nutritional deficiencies and short- and long-term complications is required to completely assess outcomes of these procedures.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: INTRODUCTION: Being overweight is widespread in most societies and represents a major health threat. Gastric bypass surgery offers a highly effective mode of treatment for the morbidly obese patients. The procedures cause an alteration in normal gastrointestinal anatomy and physiology, with consequences not only on nutrient absorption, but also possibly on orally administered drugs. Bypass of the acidic environment of the stomach, partial impairment of bile salts-drug interactions and reduced absorptive surface, all create the potential for reduced absorption of drugs. AREAS COVERED: This article provides an overview of the effects of obesity and the most prevalent type of gastric bypass (Roux-en-Y) on pharmacokinetics. Articles for review were searched using Pubmed. EXPERT OPINION: The absorption of those drugs with known bioavailability issues generally seem to be most affected by bypass surgery. It is important to consider the effect of obesity on pharmacokinetics independent of the bypass procedure, because it leads to a dramatic drop in body mass over a relatively short period of time. This may be associated with reversals in the influence of obesity on drug disposition to characteristics more in line with leaner patients. Drugs will differ in their pharmacokinetic response to surgery, limiting any general conclusions regarding the impact of the surgery on drug disposition.
    Expert Opinion on Drug Metabolism &amp Toxicology 12/2012; · 2.94 Impact Factor
  • Surgery for Obesity and Related Diseases 09/2006; 2(5):573-578. · 4.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: The primary goals of this interdisciplinary consensus statement are to define the eligibility criteria for outpatient thyroidectomy, and to explore preoperative, intraoperative and postoperative factors that should be considered in order to optimize the safe and efficient performance of ambulatory surgery. Summary: A series of criteria was developed that may represent relative contraindications to outpatient thyroidectomy, and these fell into the following broad categories: clinical, social and procedural issues. Intraoperative factors that bear consideration are enumerated, and include choice of anesthesia, use of nerve monitoring, hemostasis, management of the parathyroid glands, wound closure and extubation. Importantly, postoperative factors are described at length including suggested discharge criteria and recognition of complications, especially bleeding, airway distress, and hypocalcemia. Conclusions: Outpatient thyroidectomy may be undertaken safely in a carefully selected patient population provided certain precautionary measures are taken to maximize communication and minimize the likelihood of complications.
    Thyroid: official journal of the American Thyroid Association 06/2013; · 2.60 Impact Factor

Full-text (2 Sources)

Available from
May 26, 2014